The Record Printed Four Days Late

Three weekday papers, Monday’s, Tuesday’s and Wednesday’s, and one honest headline. The S&P 500 closed at a record on Tuesday, four days after the date we set for it. The lead, A Record 7,818.93 Crossed the Line We Named as Our Falsifier. We Were Wrong on Timing — and We’re Still Not Chasing, is the grade and the reasons the rules don’t change. A record built on a handful of stocks, with more new lows than highs on the day, is not the broad bid the September letter was waiting for. The life side leads, as always, with Warren Buffett’s YouTube nights, Formula One’s shared time-zone lie, Musk versus Delta over plane Wi-Fi, 80,000 Britons in a queue for the Bayeux Tapestry, a jeweler planning for $8,000 gold, a $50,000 “Temu Range Rover,” grip strength as a vital sign, a 48-minute robotaxi ride to the airport, middle-schoolers with AI friends, passports going online, Levi’s ’90s revival, two drillers who bought Oklahoma City a team and left, two Nobels that took decades, a KGB defector’s hinge point, a 7-Eleven clerk turned playoff starter, a Harvard coach who rehearses the miracle, the Rams at 3.2%, a $3 million quarterback and baseball’s cap fight. Your Money runs the family ledger: 2027 Part D premiums, the $90 Medicare deposits, the Supreme Court on 401(k) alternatives, single stocks in children’s accounts, a tax-reform wish list, consumers who keep spending, energy bills at the kitchen table, truckers at the Flying J, $10,000-a-year kids’ baseball, an op-ed cheering 7.28% mortgages, $10,000-a-month senior housing, Wall Street bonuses, special CEO awards, rules for AI agents and the next wave of obesity drugs. Then the markets: the Fed’s referees, what your index fund actually owns, bank stocks and the ghosts of 2023, insiders selling, France’s bill, the French bond trade that backfired, Paramount’s $52 billion day, commercial real estate retrading, Hormuz without diesel, the shuttle tankers, Greg Ip on oil shocks, Google’s nuclear deal, luxury at Zara prices, Oura and the one-hit wonders, and the AI backlash. Monday’s Journal Report on investing runs as its own edition, No. 181. It covers the adviser, the 4% rule, IRA mistakes, Medicare at 65, estate fights and the fund scorecard.

Two sessions, two records. On Monday the Nasdaq closed at a record 27,477.31. The 10-year settled at 5.310% after touching 5.349% intraday, its highest in 24 years. Stocks and yields rose together on AI optimism and inflation worry. On Tuesday the S&P 500 added 0.58% to 7,818.93, its first record since Aug. 13. The Nasdaq rose 0.45% to 27,599.79, and the Dow gained 253.38 points, or 0.49%, to 51,521.28. The 10-year eased to 5.270% and the 2-year to 4.789%. Utilities led, up 2.59%, on Google’s 20-year nuclear deal with Constellation Energy. Biotech fell 2.12%, and the Russell 2000 lost 0.59%. Underneath the record, the NYSE logged 50 new highs and 134 new lows, and fewer than half of S&P 500 stocks closed above their 200-day average. Crude settled at $89.44, and gold rose 0.75% to $4,159.20. Bankrate’s 30-year mortgage climbed to 7.47% from 7.23%, a 52-week high. The ICE BofA High Yield 100 yield eased to 7.439%. The VIX closed at 15.01, down 3.29%. Next dates: FOMC minutes Wednesday · big banks report next week · the Fed Oct. 27–28 · the vote Nov. 3.

Signals point to a calm surface and a narrow floor. The volatility index (VIX) closed at 15.01, down 3.29% on the day and far from stress. The 10-year eased to 5.27% from a 24-year intraday high the day before. The high-yield index yield slipped to 7.439%, and the October-hike scare faded to about 25%. Against that, the record came with 134 NYSE stocks at new lows against 50 at new highs, the Russell 2000 down 0.59%, and fewer than half of S&P 500 members above their 200-day average. That is the kind of day the March and September letters called distribution rather than a broad bid. The crowd now prices one more hike by December (65% on two hikes in 2026, per the Journal’s Polymarket box), and Bankrate’s 30-year mortgage jumped to 7.47%. We could not pull the VIX term structure, vol-of-vol or SKEW this session. So the read leans on the paper’s close, and we hold it at medium-low confidence. The September letter’s conditions for new money still fail on inflation and the Fed. The next inputs are Wednesday’s FOMC minutes, the banks next week and the Fed on Oct. 27–28. None of this is a forecast.

The Journal’s own crowd market (Polymarket, “a Dow Jones partner,” 2:30 p.m. ET Tuesday, $877,683 traded) asked how many Fed hikes in 2026. Two hikes 65%, one hike 22%, three 10%, four 1%. Our read: September’s increase plus one more by December is the favorite. October isn’t. Monday’s box asked how many cuts in 2026: zero, 96%.

The hike odds, per Nick Timiraos: about 70% on an October increase after Chairman Warsh explained September’s hike. Then about 25% after Fed officials John Williams and Philip Jefferson spoke, and lower still after Friday’s jobs report. The meeting is Oct. 27–28, six days before the midterms. We could not pull Polymarket directly this session. These are the Journal’s printed figures.

The borrowing table. Bankrate’s 30-year fixed is 7.47% (7.23% a week earlier) and the 15-year 6.87%, both 52-week highs. The 5/1 ARM is 6.70%, from 6.23%. Freddie Mac shows 7.28%. A 48-month new-car loan is 6.93%. The average five-year CD pays 1.78% against a 5.00% top offer, and a 13-week bill pays 4.050%.

Market-implied expectations, not forecasts. They move intraday and have been wrong before. Not investment advice.

Three sittings, none of them a forecast. First, the record. Pull up your largest account and add up the top ten holdings. If a handful of names carried your year the way they carried the index, that is the number to know before the banks report next week. It is not a reason to sell. It is a reason to size. Second, the Investing Monthly. Monday’s Journal Report runs as its own edition, No. 181. Start with the money editor who hired a fee-only adviser at 50, and the checklist he was handed before anyone talked about stocks. Third, the deadlines with dates. Medicare’s drug-plan choices are out. Stand-alone Part D premiums average $36, and the drug out-of-pocket cap is $2,100. A one-time $90 deposit toward Part B lands for more than 20 million seniors on or around Oct. 8. A check is a check, not a premium cut.

No. 181 · the Journal Report on investing · The September Letter · When, Not If · On Path · the falsifier, written down · The North Star · No. 179 · the weekend paper + Friday · Capital Wealth Growth Portfolio